Konstantinos Syrigos to Venous Thromboembolism
This is a "connection" page, showing publications Konstantinos Syrigos has written about Venous Thromboembolism.
Connection Strength
1.985
-
Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing. Thromb Res. 2021 08; 204:134-135.
Score: 0.243
-
Venous thromboembolism in COVID-19: A systematic review and meta-analysis. Vasc Med. 2021 08; 26(4):415-425.
Score: 0.240
-
Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. In Vivo. 2021 Jan-Feb; 35(1):653-661.
Score: 0.236
-
Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications. Br J Haematol. 2020 08; 190(4):529-532.
Score: 0.229
-
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020 06; 189(5):846-847.
Score: 0.225
-
Response to the letter to the editor: "New data for venous thromboembolism in patients with small cell lung cancer: A review". Phlebology. 2019 03; 34(2):139-140.
Score: 0.203
-
Khorana Score: ?ew Predictor of Early Mortality in Patients With Lung Adenocarcinoma. Clin Appl Thromb Hemost. 2018 Nov; 24(8):1347-1351.
Score: 0.197
-
New data for venous thromboembolism in patients with small cell lung cancer: A review. Phlebology. 2018 Sep; 33(8):517-522.
Score: 0.189
-
The use of novel oral anticoagulants in cancer patients with venous thromboembolism. Semin Oncol. 2016 Dec; 43(6):655-665.
Score: 0.177
-
The Role of Tinzaparin in Oncology. Clin Appl Thromb Hemost. 2018 Jul; 24(5):697-707.
Score: 0.047